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The purpose of this review is to summarize literature that describes the impact of exercise on health and physical function
among children during and after treatment for cancer. Relevant studies were identiﬁed by entering the following search terms into
Pubmed: aerobic training; resistance training; stretching; pediatric; children; AND cancer. Reference lists in retrieved manuscripts
were also reviewed to identify additional trials. We include ﬁfteen intervention trials published between 1993 and 2011 that
included children younger than age 21 years with cancer diagnoses. Nine included children with an acute lymphoblastic leukemia
(ALL) diagnosis, and six children with mixed cancer diagnoses. Generally, interventions tested were either in-hospital supervised
exercise training or home based programs designed to promote physical activity. Early evidence from small studies indicates that
the eﬀects of exercise include increased cardiopulmonary ﬁtness, improved muscle strength and ﬂexibility, reduced fatigue and
improvedphysicalfunction.Generalizationstotheentirechildhoodcancerandchildhoodcancersurvivorpopulationsarediﬃcult
as most of the work has been done in children during treatment for and among survivors of ALL. Additional randomized studies
are needed to conﬁrm these beneﬁts in larger populations of children with ALL, and in populations with cancer diagnoses other
than ALL.
1.Introduction
Progress in treatments for childhood cancer have greatly
improved cure rates, with 5-year survival now approaching
80% [1]. This has resulted in a growing population of
childhood cancer survivors. In 2006, there were more than
11 million cancer survivors in the United States; three times
the number of survivors in 1971 [2]. It is estimated that
1 in 810 individuals under the age of 20 is a survivor of
childhood cancer and that 1 in 640 individuals between the
ages of 20 and 39 years has successfully survived childhood
cancer [3]. Improving survival rates, however, does not come
without consequences. Treatment of childhood cancer is
associated with a spectrum of late eﬀects, including impaired
growth and development, cognitive dysfunction, dimin-
ished neurological function, cardiopulmonary compromise,
musculoskeletal sequelae, and secondary malignancy [4–6].
Oeﬃnger et al. [6] reported that one-third of childhood
cancer survivors have severe or life-threatening medical
complications 30 years after diagnosis. Therefore, attention
today is focused not only on survival but also on the quality
of survival.
Impaired physical ﬁtness has been reported during and
after childhood cancer treatment [7–12]. Impaired physical
ﬁtnesstypicallyincludes reducedcardiopulmonary function,
decreased muscle strength, fatigue, and altered physical
function. Treatments for childhood cancer, including radio-
therapy, chemotherapy, and surgery, can result in acute
and long-term injury to the heart, lungs, and skeletal
muscles, systems necessary for optimal physical ﬁtness [8,
13–19]. Additionally, reduced levels of physical activity
both during and after treatment for childhood cancer can
contribute to cardiac deconditioning and skeletal muscle
atrophy, ultimately limiting opportunities for participation
in recreational activities and life roles that are dependent
on adequate physical ﬁtness. Exercise intervention has the
potential to improve cardiopulmonary and musculoskeletal
function, perhaps preventing long-term deﬁcits in physical
ﬁtness if incorporated during or soon after treatment in
children with cancer diagnoses [20–24].2 International Journal of Pediatrics
Another factor that may be associated with impaired
physical ﬁtness among childhood cancer survivors is cancer-
related fatigue. Fatigue during and after treatment has the
potential to have a negative impact on physical activity
and on psychosocial well-being. A recent study reported
that the prevalence of cancer-related fatigue was over three
times higher in long-term survivors of childhood cancer
when compared to the general population (OR: 3.29; 95%
CI: 1.9–5.70) [25]. In another investigation that evaluated
associations between demographic and medical factors and
health-related quality of life (HRQOL) among pediatric
cancersurvivors,Meeskeetal.[26]foundthatfatiguewasthe
most powerful predictor of functional status and HRQOL.
Giventhatthereisevidencethatexerciseandphysicalactivity
programs can reduce fatigue, and enhance psychosocial
health in survivors of adult cancer, such interventions may
have a similar eﬀect in the pediatric population [27].
This review of the literature indicates that there is
growing evidence for the positive eﬀects of physical training
on organ system function, fatigue and physical well-being
in children during and after treatment for cancer [20,
28]. However, the optimal intervention modality and the
intensity, timing, and duration of the intervention are
diﬃcult to determine. In the published literature, very few
exercise interventions undertaken in the pediatric cancer or
pediatric cancer survivor populations have been randomized
clinical trials, and, across studies, the components of aerobic
training, resistance, and ﬂexibility exercises are implemented
with diﬀering intensity, timing, and duration. In addition,
the sample sizes are small, limited primarily to study
populations with acute leukemia diagnoses, and include
widely varied outcome measures, making it diﬃcult to draw
ﬁrm conclusions or compare results between trials. We sum-
marize here the literature that describes the eﬀects of exercise
intervention on immune system function, cardiopulmonary
health, skeletal muscle strength, fatigue, and overall physical
well-being among children during and after treatment for
cancer.
2.MethodsandSearchResults
This paper summarizes exercise intervention studies among
children with cancer and is limited to studies that tested or
described exercise intervention in children diagnosed with
a primary pediatric cancer when younger than 21 years
of age, and, includes only manuscripts available as full-
text in the English language. Studies were identiﬁed by
searching the PUBMED database with the terms exercise;
aerobic training; resistance training; stretching; pediatric;
children; cancer. Reference lists of retrieved studies were
also assessed to identify additional trials. The search of the
Pubmed database initially resulted in a total of 48 citations.
Of these, we excluded 31 citations (3 review only, 5 not
available in English, 17 no exercise intervention, and 6 adult-
cancer survivors only). We include 17 published manuscripts
documenting 15 studies published by June of 2011. A review
of the reference lists from the retrieved manuscripts did not
identifyanyadditionalpapers.Whenreportingtheoutcomes
of each study, if numerical results were available, eﬀect
sizes were converted to Cohen’s d, representing standard
deviations of change or diﬀerences in standard deviations
between groups [29], to allow for easier comparison of the
magnitude of the exercise intervention responses among
studies.
2.1. Exercise Intervention Studies among Pediatric Survivors.
A summary of the 15 published studies included in this
review examining exercise intervention for children with
cancer is shown in Tables 1 and 2. A total of 302 children
with cancer, survivors of childhood cancer, or normal
controls participated in the 15 trials; 46 were young adults
[30] and 256 were children or adolescents [21–23, 31–
43]. Of these 15 exercise interventions during or after
pediatric cancer treatment, seven included a control group
or control intervention, nine employed supervised training
with aerobic, resistance, and/or ﬂexibility training with or
without home-based exercises [21–23, 31–40, 43], ﬁve tested
enhanced physical activity (EPA) interventions [30, 34, 36,
39, 42], and one used an individualized home-based exercise
program [41]. We diﬀerentiate between nonrandomized
(Table 1) and randomized trials (Table 2) to highlight the
need for additional experimental evidence to evaluate the
eﬀects of exercise intervention for children with cancer.
Only 121 children with cancer diagnoses have participated
in four randomized controlled trials; 41 were children and
adolescents with ALL during maintenance chemotherapy
[21, 36] and 70 were the survivors of childhood cancer
with mixed diagnoses [33, 42]. We also diﬀerentiate between
exercise and EPA by noting that exercise implies a speciﬁc
training regimen with established frequency, intensity, and
durationandthatEPAincludesdynamicactivitiescompleted
during the performance of everyday tasks [44]. The majority
of the interventions included only patients with acute
lymphoblastic leukemia (ALL) diagnoses; only six studies
were done in study populations with mixed diagnoses [30,
31, 34, 38, 39, 42]. One study was completed in children with
ALL during the ﬁrst six months of medical treatment [32],
and six were completed among children with ALL during
the maintenance or continuation phase of medical treatment
[21, 23, 35–37, 43]. Outcome measures described included
(1) immunological function [31, 35], (2) cardiovascular
ﬁtness [21–23, 35, 36, 38, 40], (3) muscle strength and
ﬂexibility [21–23, 33, 34, 36, 40, 43], (4) fatigue or sleep
eﬃcacy [30, 34, 40–42], (5) general physical function [9, 21,
32, 33, 36, 40], and (6) quality of life [9, 21, 32, 34, 39].
2.2. Eﬀect of Exercise on Immune Suppression and Growth
Factors. Chemotherapy treatment for pediatric cancer sup-
presses the immune system and may interfere with normal
growth, increasing susceptibility to infection and stunting
or delaying musculoskeletal development during treatment
[45–47]. Concern about the eﬀects of exercise on immune
function and growth factors includes the possibility that
exercise may tax an already compromised immune or
endocrine systemand eitherdelay recoveryorfurtherimpact
normal skeletal growth [48]. A pilot study by Ladha et al.International Journal of Pediatrics 3
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h
y
s
i
c
a
l
a
c
t
i
v
i
t
i
e
s
i
n
t
h
e
ﬁ
n
a
l
8
w
e
e
k
s
)
D
u
r
a
t
i
o
n
:
1
6
w
e
e
k
s
,
a
g
r
o
u
p
-
b
a
s
e
d
p
h
y
s
i
c
a
l
a
c
t
i
v
i
t
y
i
n
t
e
r
v
e
n
t
i
o
n
.
A
t
t
e
n
d
a
n
c
e
r
a
t
e
:
8
1
.
5
%
o
v
e
r
1
6
-
w
e
e
k
i
n
t
e
r
v
e
n
t
i
o
n
.
U
p
p
e
r
b
o
d
y
s
t
r
e
n
g
t
h
(
+
)
,
ﬂ
e
x
i
b
i
l
i
t
y
(
+
)
,
t
o
t
a
l
P
A
(
+
)
,
Q
O
L
(
+
)
,
a
n
d
g
e
n
e
r
a
l
f
a
t
i
g
u
e
(
+
)
.
P
a
r
t
i
c
i
p
a
n
t
s
f
a
i
l
e
d
t
o
m
a
i
n
t
a
i
n
t
h
e
i
r
p
o
s
t
i
n
t
e
r
v
e
n
t
i
o
n
P
A
l
e
v
e
l
s
a
t
b
o
t
h
3
-
a
n
d
1
2
-
m
o
n
t
h
f
o
l
l
o
w
-
u
p
t
i
m
e
p
o
i
n
t
s
.
S
a
n
J
u
a
n
,
2
0
0
8
[
2
2
]
.
P
r
e
t
e
s
t
/
p
o
s
t
t
e
s
t
t
r
i
a
l
.
N
=
8
.
C
h
i
l
d
r
e
n
a
f
t
e
r
H
C
T
f
o
r
l
e
u
k
e
m
i
a
.
4
b
o
y
s
.
M
e
a
n
a
g
e
a
t
t
h
e
t
i
m
e
o
f
t
h
e
s
t
u
d
y
:
1
0
.
9
±
2
.
8
y
r
s
.
I
n
t
e
r
v
e
n
t
i
o
n
:
t
h
r
e
e
w
e
e
k
l
y
s
e
s
s
i
o
n
s
(
9
0
–
1
2
0
m
i
n
u
t
e
s
)
o
f
s
u
p
e
r
v
i
s
e
d
r
e
s
i
s
t
a
n
c
e
t
r
a
i
n
i
n
g
(
b
e
n
c
h
p
r
e
s
s
,
s
h
o
u
l
d
e
r
p
r
e
s
s
,
l
e
g
e
x
t
e
n
s
i
o
n
,
l
e
g
c
u
r
l
,
l
e
g
p
r
e
s
s
,
a
b
d
o
m
i
n
a
l
c
r
u
n
c
h
,
l
o
w
e
r
-
b
a
c
k
e
x
t
e
n
s
i
o
n
,
a
r
m
c
u
r
l
,
e
l
b
o
w
e
x
t
e
n
s
i
o
n
,
s
e
a
t
e
d
r
o
w
,
a
n
d
l
a
t
e
r
a
l
p
u
l
l
-
d
o
w
n
;
1
1
r
e
p
e
t
i
t
i
o
n
s
)
a
n
d
a
e
r
o
b
i
c
e
x
e
r
c
i
s
e
(
s
t
a
r
t
e
d
w
i
t
h
1
0
m
i
n
u
t
e
s
o
f
e
x
e
r
c
i
s
e
s
a
t
5
0
%
o
f
a
g
e
-
p
r
e
d
i
c
t
e
d
H
R
m
a
x
a
n
d
p
r
o
g
r
e
s
s
e
d
t
o
3
0
m
i
n
u
t
e
s
o
f
c
o
n
t
i
n
u
o
u
s
e
x
e
r
c
i
s
e
a
t
≥
7
0
%
H
R
m
a
x
b
y
t
h
e
e
n
d
o
f
t
h
e
p
r
o
g
r
a
m
)
D
u
r
a
t
i
o
n
:
8
w
e
e
k
s
,
d
u
r
i
n
g
t
r
e
a
t
m
e
n
t
M
u
s
c
l
e
s
t
r
e
n
g
t
h
(
+
)
,
V
O
2
p
e
a
k
(
+
)
,
f
u
n
c
t
i
o
n
a
l
m
o
b
i
l
i
t
y
(
+
)
(
T
U
D
s
,
3
-
a
n
d
1
0
-
m
e
t
e
r
T
U
G
)
a
n
d
s
e
l
f
-
r
e
p
o
r
t
e
d
h
e
a
l
t
h
s
t
a
t
u
s
(
+
)
.
B
M
I
(
−
)
,
a
c
t
i
v
e
a
n
d
p
a
s
s
i
v
e
d
o
r
s
i
ﬂ
e
x
i
o
n
r
a
n
g
e
o
f
m
o
t
i
o
n
(
−
)
,
V
T
(
−
)
,
o
r
H
m
a
x
(
−
)
.
T
a
k
k
e
n
,
2
0
0
9
[
4
0
]
.
P
r
e
t
e
s
t
/
p
o
s
t
t
e
s
t
t
r
i
a
l
.
N
=
9
.
C
h
i
l
d
r
e
n
w
i
t
h
A
L
L
.
M
e
a
n
a
g
e
a
t
t
h
e
t
i
m
e
o
f
t
h
e
s
t
u
d
y
:
9
.
3
±
3
.
2
(
r
a
n
g
e
6
–
1
4
)
y
r
s
I
n
t
e
r
v
e
n
t
i
o
n
:
t
w
o
w
e
e
k
l
y
s
e
s
s
i
o
n
s
(
4
5
m
i
n
u
t
e
s
)
o
f
s
u
p
e
r
v
i
s
e
d
r
e
s
i
s
t
a
n
c
e
t
r
a
i
n
i
n
g
(
s
i
t
-
u
p
s
,
p
u
s
h
-
u
p
s
,
h
e
a
d
a
n
d
l
e
g
r
a
i
s
e
s
;
3
0
-
s
e
c
o
n
d
r
e
p
e
t
i
t
i
o
n
m
a
x
i
m
u
m
a
n
d
s
q
u
a
t
s
6
0
-
s
e
c
o
n
d
r
e
p
e
t
i
t
i
o
n
m
a
x
i
m
u
m
)
,
a
e
r
o
b
i
c
e
x
e
r
c
i
s
e
(
6
6
–
7
7
%
o
f
H
R
m
a
x
i
n
ﬁ
r
s
t
4
w
e
e
k
s
,
7
7
–
9
0
%
H
R
m
a
x
i
n
t
h
e
f
o
l
l
o
w
i
n
g
4
w
e
e
k
s
,
a
n
d
≥
9
0
%
H
R
m
a
x
i
n
t
h
e
l
a
s
t
4
w
e
e
k
s
)
a
n
d
a
h
o
m
e
-
b
a
s
e
d
e
x
e
r
c
i
s
e
p
r
o
g
r
a
m
(
s
t
r
e
n
g
t
h
,
ﬂ
e
x
i
b
i
l
i
t
y
,
a
n
d
a
e
r
o
b
i
c
ﬁ
t
n
e
s
s
)
.
D
u
r
a
t
i
o
n
:
1
2
w
e
e
k
s
,
c
o
m
m
u
n
i
t
y
-
b
a
s
e
d
e
x
e
r
c
i
s
e
p
r
o
g
r
a
m
S
e
v
e
n
t
y
p
e
r
c
e
n
t
o
f
t
r
a
i
n
e
r
s
w
e
r
e
s
a
t
i
s
ﬁ
e
d
w
i
t
h
t
h
e
p
r
o
g
r
a
m
.
B
M
I
(
−
)
,
m
u
s
c
l
e
s
t
r
e
n
g
t
h
(
−
)
,
e
x
e
r
c
i
s
e
c
a
p
a
c
i
t
y
(
−
)
,
f
u
n
c
t
i
o
n
a
l
m
o
b
i
l
i
t
y
(
−
)
,
o
r
f
a
t
i
g
u
e
l
e
v
e
l
s
(
−
)
.
B
l
a
a
u
w
b
r
o
e
k
,
2
0
0
9
[
3
0
]
.
P
r
e
t
e
s
t
/
p
o
s
t
t
e
s
t
t
r
i
a
l
.
N
=
3
8
.
A
d
u
l
t
s
u
r
v
i
v
o
r
s
o
f
c
h
i
l
d
h
o
o
d
c
a
n
c
e
r
(
m
i
x
e
d
c
a
n
c
e
r
t
y
p
e
s
)
.
1
4
m
a
l
e
s
.
A
g
e
a
t
d
i
a
g
n
o
s
i
s
8
.
1
±
6
.
7
y
e
a
r
s
;
t
i
m
e
s
i
n
c
e
d
i
a
g
n
o
s
i
s
2
1
.
8
±
7
.
1
y
e
a
r
s
.
M
e
a
n
a
g
e
a
t
t
h
e
t
i
m
e
o
f
t
h
e
s
t
u
d
y
:
2
9
.
8
±
8
.
6
y
r
s
I
n
t
e
r
v
e
n
t
i
o
n
:
e
n
h
a
n
c
e
d
p
h
y
s
i
c
a
l
a
c
t
i
v
i
t
y
(
s
u
c
h
a
s
w
a
l
k
i
n
g
,
c
y
c
l
i
n
g
,
h
o
u
s
e
k
e
e
p
i
n
g
,
a
n
d
g
a
r
d
e
n
i
n
g
)
c
o
u
n
s
e
l
i
n
g
.
T
h
e
c
o
u
n
s
e
l
o
r
e
n
c
o
u
r
a
g
e
d
t
h
e
s
u
r
v
i
v
o
r
s
t
o
c
h
a
n
g
e
t
h
e
i
r
l
i
f
e
s
t
y
l
e
a
n
d
e
n
h
a
n
c
e
d
a
i
l
y
p
h
y
s
i
c
a
l
a
c
t
i
v
i
t
y
t
o
m
e
e
t
p
u
b
l
i
s
h
e
d
e
x
e
r
c
i
s
e
g
u
i
d
e
l
i
n
e
s
(
i
.
e
.
,
a
t
l
e
a
s
t
1
5
0
m
i
n
u
t
e
s
o
f
m
o
d
e
r
a
t
e
-
t
o
-
v
i
g
o
r
o
u
s
e
x
e
r
c
i
s
e
/
w
e
e
k
)
a
n
d
p
h
o
n
e
d
t
h
e
s
u
r
v
i
v
o
r
s
a
t
t
h
r
e
e
w
e
e
k
s
,
s
i
x
w
e
e
k
s
,
a
n
d
n
i
c
e
w
e
e
k
s
t
o
c
h
e
c
k
g
o
a
l
s
.
F
e
e
d
b
a
c
k
f
r
o
m
a
p
e
d
o
m
e
t
e
r
.
D
u
r
a
t
i
o
n
:
1
0
w
e
e
k
s
o
f
c
o
u
n
s
e
l
i
n
g
.
S
i
g
n
i
ﬁ
c
a
n
t
i
m
p
r
o
v
e
m
e
n
t
s
i
n
f
a
t
i
g
u
e
a
n
d
d
a
i
l
y
s
t
e
p
s
a
f
t
e
r
i
n
t
e
r
v
e
n
t
i
o
n
.
T
h
e
r
e
w
a
s
a
l
o
w
c
o
r
r
e
l
a
t
i
o
n
(
0
.
1
2
)
b
e
t
w
e
e
n
i
n
c
r
e
a
s
e
i
n
d
a
i
l
y
s
t
e
p
s
a
n
d
t
h
e
d
e
c
r
e
a
s
e
i
n
f
a
t
i
g
u
e
.International Journal of Pediatrics 5
T
a
b
l
e
1
:
C
o
n
t
i
n
u
e
d
.
F
i
r
s
t
a
u
t
h
o
r
a
n
d
y
e
a
r
D
e
s
i
g
n
D
e
m
o
g
r
a
p
h
i
c
s
E
x
e
r
c
i
s
e
i
n
t
e
r
v
e
n
t
i
o
n
(
t
y
p
e
o
f
t
r
a
i
n
i
n
g
,
f
r
e
q
u
e
n
c
y
,
a
n
d
d
u
r
a
t
i
o
n
)
∗
M
a
i
n
o
u
t
c
o
m
e
s
S
p
e
y
e
r
,
2
0
1
0
[
3
9
]
.
C
r
o
s
s
-
o
v
e
r
,
s
i
n
g
l
e
s
t
u
d
y
d
e
s
i
g
n
.
N
=
3
0
.
C
h
i
l
d
r
e
n
w
i
t
h
c
a
n
c
e
r
(
h
e
m
a
t
o
l
o
g
i
c
m
a
l
i
g
n
a
n
c
y
:
1
5
,
s
o
l
i
d
t
u
m
o
r
s
:
1
2
,
u
n
k
n
o
w
n
:
3
)
.
1
8
m
a
l
e
s
.
M
e
a
n
a
g
e
a
t
t
h
e
t
i
m
e
o
f
t
h
e
s
t
u
d
y
:
1
3
.
6
±
2
.
9
y
r
s
.
I
n
t
e
r
v
e
n
t
i
o
n
:
t
h
r
e
e
w
e
e
k
l
y
s
e
s
s
i
o
n
s
(
3
0
m
i
n
u
t
e
s
)
o
f
a
d
a
p
t
e
d
p
h
y
s
i
c
a
l
a
c
t
i
v
i
t
y
(
b
a
l
l
g
a
m
e
s
,
c
i
r
c
u
s
a
r
t
s
,
t
h
r
o
w
i
n
g
g
a
m
e
s
,
s
h
o
o
t
i
n
g
g
a
m
e
s
,
r
a
c
k
e
t
s
p
o
r
t
s
,
v
i
d
e
o
g
a
m
e
s
,
a
n
d
b
o
d
y
b
u
i
l
d
i
n
g
)
.
C
o
n
t
r
o
l
:
s
t
a
n
d
a
r
d
c
a
r
e
w
i
t
h
o
u
t
a
d
a
p
t
e
d
p
h
y
s
i
c
a
l
a
c
t
i
v
i
t
y
.
D
u
r
a
t
i
o
n
:
f
o
u
r
p
e
r
i
o
d
s
o
f
e
n
h
a
n
c
e
d
p
h
y
s
i
c
a
l
a
c
t
i
v
i
t
y
(
c
r
o
s
s
-
o
v
e
r
)
.
Q
O
L
s
c
o
r
e
s
i
n
p
h
y
s
i
c
a
l
a
n
d
p
s
y
c
h
o
l
o
g
i
c
a
l
d
i
m
e
n
s
i
o
n
s
w
e
r
e
h
i
g
h
e
r
f
o
r
t
h
e
c
h
i
l
d
r
e
n
w
h
o
p
r
a
c
t
i
c
e
d
t
h
a
n
f
o
r
t
h
o
s
e
w
h
o
d
i
d
n
o
t
p
r
a
c
t
i
c
e
a
d
a
p
t
e
d
p
h
y
s
i
c
a
l
a
c
t
i
v
i
t
y
d
u
r
i
n
g
h
o
s
p
i
t
a
l
i
z
a
t
i
o
n
.
C
h
a
m
o
r
r
o
-
V
i
n
a
,
2
0
1
0
[
3
1
]
.
N
o
n
r
a
n
d
o
m
i
z
e
d
c
o
n
t
r
o
l
l
e
d
t
r
i
a
l
.
I
n
t
e
r
v
e
n
t
i
o
n
g
r
o
u
p
:
N
=
7
.
C
h
i
l
d
r
e
n
w
h
o
h
a
d
u
n
d
e
r
g
o
n
e
H
C
T
.
5
b
o
y
s
.
M
e
a
n
a
g
e
a
t
t
h
e
t
i
m
e
o
f
t
h
e
s
t
u
d
y
:
8
±
4
y
r
s
.
C
o
n
t
r
o
l
g
r
o
u
p
:
N
=
1
3
.
9
b
o
y
s
.
M
e
a
n
a
g
e
a
t
t
h
e
t
i
m
e
o
f
t
h
e
s
t
u
d
y
:
7
±
3
y
r
s
.
I
n
t
e
r
v
e
n
t
i
o
n
:
F
i
v
e
w
e
e
k
l
y
s
e
s
s
i
o
n
s
(
∼
5
0
m
i
n
u
t
e
s
)
o
f
s
u
p
e
r
v
i
s
e
d
r
e
s
i
s
t
a
n
c
e
t
r
a
i
n
i
n
g
(
a
r
m
c
u
r
l
,
e
l
b
o
w
e
x
t
e
n
s
i
o
n
,
b
e
n
c
h
p
r
e
s
s
,
l
o
g
e
x
t
e
n
s
i
o
n
,
h
a
l
f
s
q
u
a
t
,
a
b
d
o
m
i
n
a
l
c
r
u
n
c
h
,
s
u
p
i
n
e
b
r
i
d
g
e
,
a
n
d
r
o
w
i
n
g
;
1
2
–
1
5
r
e
p
e
t
i
t
i
o
n
s
)
(
s
t
r
e
t
c
h
i
n
g
e
x
e
r
c
i
s
e
i
n
v
o
l
v
i
n
g
a
l
l
m
a
j
o
r
m
u
s
c
l
e
g
r
o
u
p
s
)
a
n
d
a
e
r
o
b
i
c
e
x
e
r
c
i
s
e
(
1
0
–
4
0
m
i
n
u
t
e
s
o
f
c
y
c
l
e
e
r
g
o
m
e
t
r
y
a
t
5
0
%
t
o
7
0
%
o
f
H
R
m
a
x
)
.
C
o
n
t
r
o
l
:
s
t
a
n
d
a
r
d
c
a
r
e
.
D
u
r
a
t
i
o
n
:
3
w
e
e
k
s
,
d
u
r
i
n
g
t
r
e
a
t
m
e
n
t
.
F
i
t
n
e
s
s
l
e
v
e
l
s
(
+
)
(
h
a
l
f
s
q
u
a
t
)
o
r
b
o
d
y
m
a
s
s
(
+
)
.
E
x
e
r
c
i
s
e
i
n
t
e
r
v
e
n
t
i
o
n
d
u
r
i
n
g
i
n
p
a
t
i
e
n
t
s
t
a
y
f
o
r
H
C
T
d
i
d
n
o
t
a
ﬀ
e
c
t
i
m
m
u
n
e
c
e
l
l
r
e
c
o
v
e
r
y
i
n
y
o
u
n
g
c
h
i
l
d
r
e
n
w
i
t
h
h
i
g
h
-
r
i
s
k
c
a
n
c
e
r
.
Y
e
h
,
2
0
1
1
[
4
1
]
.
N
o
n
r
a
n
d
o
m
i
z
e
d
c
o
n
t
r
o
l
l
e
d
t
r
i
a
l
.
I
n
t
e
r
v
e
n
t
i
o
n
g
r
o
u
p
:
N
=
1
2
.
C
h
i
l
d
r
e
n
a
n
d
a
d
o
l
e
s
c
e
n
t
s
w
i
t
h
A
L
L
.
6
b
o
y
s
.
M
e
a
n
a
g
e
a
t
t
h
e
t
i
m
e
o
f
t
h
e
s
t
u
d
y
:
1
1
±
4
y
r
s
.
C
o
n
t
r
o
l
g
r
o
u
p
:
N
=
1
0
.
6
b
o
y
s
.
M
e
a
n
a
g
e
a
t
t
h
e
t
i
m
e
o
f
t
h
e
s
t
u
d
y
:
1
2
.
5
±
4
y
r
s
.
I
n
t
e
r
v
e
n
t
i
o
n
:
t
h
r
e
e
w
e
e
k
l
y
s
e
s
s
i
o
n
s
(
3
0
m
i
n
u
t
e
s
)
o
f
i
n
d
i
v
i
d
u
a
l
i
z
e
d
h
o
m
e
-
b
a
s
e
d
a
e
r
o
b
i
c
e
x
e
r
c
i
s
e
p
r
o
g
r
a
m
(
e
x
e
r
c
i
s
e
i
n
t
e
n
s
i
t
y
:
4
0
%
–
6
0
%
o
f
H
R
R
)
C
o
n
t
r
o
l
:
s
t
a
n
d
a
r
d
c
a
r
e
D
u
r
a
t
i
o
n
:
6
w
e
e
k
s
,
d
u
r
i
n
g
t
r
e
a
t
m
e
n
t
G
e
n
e
r
a
l
f
a
t
i
g
u
e
(
+
)
.
S
l
e
e
p
/
r
e
s
t
a
n
d
c
o
g
n
i
t
i
v
e
f
a
t
i
g
u
e
s
c
o
r
e
s
(
−
)
.
G
o
h
a
r
,
2
0
1
1
[
3
2
]
.
P
r
e
t
e
s
t
/
p
o
s
t
t
e
s
t
t
r
i
a
l
.
N
=
9
.
C
h
i
l
d
r
e
n
w
i
t
h
A
L
L
.
3
m
a
l
e
s
.
M
e
d
i
a
n
a
g
e
a
t
t
i
m
e
o
f
t
h
e
s
t
u
d
y
:
4
(
r
a
n
g
e
2
–
1
4
)
y
r
s
I
n
t
e
r
v
e
n
t
i
o
n
:
i
n
d
i
v
i
d
u
a
l
i
z
e
d
h
o
m
e
-
b
a
s
e
d
e
x
e
r
c
i
s
e
p
r
o
g
r
a
m
(
s
t
r
e
t
c
h
i
n
g
e
x
e
r
c
i
s
e
:
a
n
k
l
e
d
o
r
s
i
ﬂ
e
x
i
o
n
;
5
d
a
y
s
/
w
e
e
k
,
s
t
r
e
n
g
t
h
e
n
i
n
g
e
x
e
r
c
i
s
e
:
l
o
w
e
r
-
a
n
d
u
p
p
e
r
-
e
x
t
r
e
m
i
t
y
e
x
e
r
c
i
s
e
;
1
0
r
e
p
e
t
i
t
i
o
n
s
5
d
a
y
s
/
w
e
e
k
,
a
n
d
a
e
r
o
b
i
c
e
x
e
r
c
i
s
e
:
w
a
l
k
i
n
g
,
b
i
k
e
r
i
d
i
n
g
,
a
n
d
d
a
n
c
i
n
g
1
0
–
3
0
m
i
n
u
t
e
s
;
5
d
a
y
s
/
w
e
e
k
)
.
D
u
r
a
t
i
o
n
:
6
-
7
m
o
n
t
h
s
,
d
u
r
i
n
g
t
r
e
a
t
m
e
n
t
.
G
r
o
s
s
m
o
t
o
r
f
u
n
c
t
i
o
n
(
+
)
a
n
d
Q
O
L
m
e
a
s
u
r
e
s
(
+
)
t
h
r
o
u
g
h
o
u
t
t
h
e
s
t
u
d
y
(
a
t
d
i
a
g
n
o
s
i
s
,
i
n
d
u
c
t
i
o
n
,
c
o
n
s
o
l
i
d
a
t
i
o
n
,
i
n
t
e
r
i
m
m
a
i
n
t
e
n
a
n
c
e
,
a
n
d
d
e
l
a
y
e
d
i
n
t
e
n
s
i
ﬁ
c
a
t
i
o
n
)
.
H
o
w
e
v
e
r
,
Q
O
L
s
c
o
r
e
s
d
e
c
r
e
a
s
e
d
f
r
o
m
i
n
t
e
r
i
m
m
a
i
n
t
e
n
a
n
c
e
t
o
d
e
l
a
y
e
d
i
n
t
e
n
s
i
ﬁ
c
a
t
i
o
n
.
T
h
e
p
a
r
e
n
t
s
r
e
p
o
r
t
e
d
b
e
i
n
g
s
a
t
i
s
ﬁ
e
d
w
i
t
h
t
h
e
P
T
p
r
o
g
r
a
m
.
∗
(
+
)
t
o
i
n
d
i
c
a
t
e
a
s
i
g
n
i
ﬁ
c
a
n
t
e
ﬀ
e
c
t
;
(
−
)
t
o
i
n
d
i
c
a
t
e
n
o
s
i
g
n
i
ﬁ
c
a
n
t
e
ﬀ
e
c
t
/
c
h
a
n
g
e
.
A
L
L
:
a
c
u
t
e
l
y
m
p
h
o
b
l
a
s
t
i
c
l
e
u
k
e
m
i
a
;
A
M
L
:
a
c
u
t
e
m
y
e
l
o
i
d
l
e
u
k
e
m
i
a
;
B
M
D
:
b
o
n
e
m
i
n
e
r
a
l
d
e
n
s
i
t
y
;
B
M
I
:
b
o
d
y
m
a
s
s
i
n
d
e
x
;
C
N
S
:
c
e
n
t
r
a
l
n
e
r
v
o
u
s
s
y
s
t
e
m
;
H
R
R
:
h
e
a
r
t
r
a
t
e
r
e
s
e
r
v
e
;
H
C
T
:
h
e
m
a
t
o
p
o
i
e
t
i
c
s
t
e
m
c
e
l
l
t
r
a
n
s
p
l
a
n
t
;
P
A
:
p
h
y
s
i
c
a
l
a
c
t
i
v
i
t
y
;
P
T
:
p
h
y
s
i
c
a
l
t
h
e
r
a
p
y
;
Q
O
L
:
q
u
a
l
i
t
y
o
f
l
i
f
e
;
V
O
2
p
e
a
k
:
p
e
a
k
a
e
r
o
b
i
c
ﬁ
t
n
e
s
s
;
H
R
m
a
x
:
m
a
x
i
m
u
m
o
f
h
e
a
r
t
r
a
t
e
;
T
U
D
s
:
t
i
m
e
u
p
a
n
d
d
o
w
n
s
t
a
i
r
t
e
s
t
;
T
U
G
:
t
i
m
e
d
u
p
a
n
d
g
o
t
e
s
t
;
V
T
:
v
e
n
t
i
l
a
t
o
r
y
t
h
r
e
s
h
o
l
d
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T
a
b
l
e
2
:
D
e
s
c
r
i
p
t
i
o
n
o
f
t
h
e
r
a
n
d
o
m
i
z
e
d
e
x
e
r
c
i
s
e
t
r
i
a
l
s
i
n
c
h
i
l
d
r
e
n
w
i
t
h
c
a
n
c
e
r
.
F
i
r
s
t
a
u
t
h
o
r
a
n
d
y
e
a
r
D
e
m
o
g
r
a
p
h
i
c
s
E
x
e
r
c
i
s
e
i
n
t
e
r
v
e
n
t
i
o
n
(
t
y
p
e
o
f
t
r
a
i
n
i
n
g
,
f
r
e
q
u
e
n
c
y
,
a
n
d
d
u
r
a
t
i
o
n
)
∗
M
a
i
n
o
u
t
c
o
m
e
s
M
a
r
c
h
e
s
e
,
2
0
0
4
[
2
1
]
.
I
n
t
e
r
v
e
n
t
i
o
n
g
r
o
u
p
:
N
=
1
3
.
A
L
L
r
e
c
e
i
v
i
n
g
m
a
i
n
t
e
n
a
n
c
e
t
h
e
r
a
p
y
.
8
m
a
l
e
s
.
M
e
a
n
a
g
e
a
t
t
h
e
t
i
m
e
o
f
t
h
e
s
t
u
d
y
:
7
.
6
(
r
a
n
g
e
,
4
.
3
–
1
0
.
6
)
y
r
s
.
C
o
n
t
r
o
l
g
r
o
u
p
:
N
=
1
5
.
1
2
m
a
l
e
s
.
M
e
a
n
a
g
e
a
t
t
h
e
t
i
m
e
o
f
t
h
e
s
t
u
d
y
:
8
.
6
(
r
a
n
g
e
5
.
1
–
1
5
.
8
)
y
r
s
I
n
t
e
r
v
e
n
t
i
o
n
:
ﬁ
v
e
s
e
s
s
i
o
n
s
(
2
0
t
o
6
0
m
i
n
u
t
e
s
i
m
m
e
d
i
a
t
e
l
y
a
f
t
e
r
i
n
i
t
i
a
l
t
e
s
t
i
n
g
,
a
n
d
2
,
4
,
8
,
a
n
d
1
2
w
e
e
k
s
l
a
t
e
r
)
o
f
P
T
(
s
t
r
e
t
c
h
i
n
g
a
n
d
s
t
r
e
n
g
t
h
e
n
i
n
g
e
x
e
r
c
i
s
e
s
,
s
u
p
e
r
v
i
s
e
d
)
a
n
d
a
n
i
n
d
i
v
i
d
u
a
l
i
z
e
d
h
o
m
e
-
b
a
s
e
d
e
x
e
r
c
i
s
e
p
r
o
g
r
a
m
(
b
i
l
a
t
e
r
a
l
a
n
k
l
e
d
o
r
s
i
ﬂ
e
x
i
o
n
s
t
r
e
t
c
h
i
n
g
f
o
r
3
0
s
e
c
5
d
a
y
s
p
e
r
w
e
e
k
,
b
i
l
a
t
e
r
a
l
l
o
w
e
r
e
x
t
r
e
m
i
t
y
s
t
r
e
n
g
t
h
e
n
i
n
g
3
s
e
t
s
,
3
d
a
y
s
p
e
r
w
e
e
k
,
a
n
d
a
e
r
o
b
i
c
e
x
e
r
c
i
s
e
s
)
.
C
o
n
t
r
o
l
:
n
o
i
n
s
t
r
u
c
t
i
o
n
s
r
e
l
a
t
e
d
t
o
p
h
y
s
i
c
a
l
ﬁ
t
n
e
s
s
a
n
d
n
o
P
T
i
n
t
e
r
v
e
n
t
i
o
n
.
D
u
r
a
t
i
o
n
:
1
6
w
e
e
k
s
,
d
u
r
i
n
g
t
r
e
a
t
m
e
n
t
.
H
e
m
o
g
l
o
b
i
n
l
e
v
e
l
(
−
)
,
a
n
k
l
e
d
o
r
s
i
ﬂ
e
x
i
o
n
s
t
r
e
n
g
t
h
(
−
)
,
T
U
D
s
(
−
)
,
9
-
m
i
n
u
t
e
w
a
l
k
-
r
u
n
(
−
)
,
a
n
d
Q
O
L
(
−
)
.
A
n
k
l
e
d
o
r
s
i
ﬂ
e
x
i
o
n
r
a
n
g
e
o
f
m
o
t
i
o
n
(
a
c
t
i
v
e
)
a
n
d
k
n
e
e
e
x
t
e
n
s
i
o
n
s
t
r
e
n
g
t
h
i
n
c
r
e
a
s
e
d
i
n
i
n
t
e
r
v
e
n
t
i
o
n
g
r
o
u
p
f
r
o
m
b
e
f
o
r
e
t
o
a
f
t
e
r
t
e
s
t
.
H
i
n
d
s
,
2
0
0
7
[
4
2
]
.
I
n
t
e
r
v
e
n
t
i
o
n
g
r
o
u
p
:
N
=
1
4
.
C
h
i
l
d
r
e
n
a
n
d
a
d
o
l
e
s
c
e
n
t
s
w
i
t
h
c
a
n
c
e
r
.
9
m
a
l
e
s
.
M
e
a
n
a
g
e
a
t
t
h
e
t
i
m
e
o
f
t
h
e
s
t
u
d
y
:
1
3
.
0
(
r
a
n
g
e
8
.
5
–
1
7
.
4
)
y
r
s
C
o
n
t
r
o
l
g
r
o
u
p
:
N
=
1
5
.
3
m
a
l
e
s
.
M
e
a
n
a
g
e
a
t
t
h
e
t
i
m
e
o
f
t
h
e
s
t
u
d
y
:
1
1
.
9
(
r
a
n
g
e
7
.
4
–
1
8
.
1
)
y
r
s
I
n
t
e
r
v
e
n
t
i
o
n
:
e
n
h
a
n
c
e
d
p
h
y
s
i
c
a
l
a
c
t
i
v
i
t
y
(
p
e
d
a
l
i
n
g
a
s
t
a
t
i
o
n
a
r
y
b
i
k
e
-
s
t
y
l
e
e
x
e
r
c
i
s
e
r
,
3
0
m
i
n
u
t
e
s
,
t
w
i
c
e
d
a
i
l
y
d
u
r
i
n
g
b
r
i
e
f
h
o
s
p
i
t
a
l
i
z
a
t
i
o
n
)
.
C
o
n
t
r
o
l
:
s
t
a
n
d
a
r
d
c
a
r
e
.
D
u
r
a
t
i
o
n
:
2
–
4
d
a
y
s
,
d
u
r
i
n
g
t
r
e
a
t
m
e
n
t
.
S
l
e
e
p
e
ﬃ
c
i
e
n
c
y
(
+
)
.
M
o
y
e
r
-
M
i
l
e
u
r
,
2
0
0
9
[
3
6
]
.
I
n
t
e
r
v
e
n
t
i
o
n
g
r
o
u
p
:
N
=
6
.
C
h
i
l
d
r
e
n
r
e
c
e
i
v
i
n
g
m
a
i
n
t
e
n
a
n
c
e
t
h
e
r
a
p
y
f
o
r
A
L
L
.
3
m
a
l
e
s
.
M
e
a
n
a
g
e
a
t
t
h
e
t
i
m
e
o
f
t
h
e
s
t
u
d
y
:
7
.
2
±
0
.
7
y
r
s
.
C
o
n
t
r
o
l
g
r
o
u
p
:
N
=
7
.
4
m
a
l
e
s
.
M
e
a
n
a
g
e
a
t
t
h
e
t
i
m
e
o
f
t
h
e
s
t
u
d
y
:
5
.
9
±
0
.
7
y
r
s
.
I
n
t
e
r
v
e
n
t
i
o
n
:
a
n
i
n
d
i
v
i
d
u
a
l
i
z
e
d
e
x
e
r
c
i
s
e
p
r
o
g
r
a
m
(
t
h
r
e
e
1
5
–
2
0
-
m
i
n
u
t
e
s
e
s
s
i
o
n
s
o
f
m
o
d
e
r
a
t
e
-
t
o
-
v
i
g
o
r
o
u
s
a
c
t
i
v
i
t
y
p
e
r
w
e
e
k
)
a
n
d
n
u
t
r
i
t
i
o
n
a
l
e
d
u
c
a
t
i
o
n
.
C
o
n
t
r
o
l
:
r
e
c
e
i
v
e
d
s
t
a
n
d
a
r
d
d
i
e
t
r
e
c
o
m
m
e
n
d
a
t
i
o
n
a
n
d
p
e
r
f
o
r
m
e
d
a
c
t
i
v
i
t
y
a
s
t
o
l
e
r
a
t
e
d
.
D
u
r
a
t
i
o
n
:
1
2
m
o
n
t
h
s
,
e
n
h
a
n
c
e
d
p
h
y
s
i
c
a
l
a
c
t
i
v
i
t
y
p
r
o
g
r
a
m
N
u
t
r
i
e
n
t
i
n
t
a
k
e
(
−
)
,
h
e
i
g
h
t
(
−
)
,
w
e
i
g
h
t
(
−
)
,
o
r
B
M
I
(
−
)
b
e
t
w
e
e
n
i
n
t
e
r
v
e
n
t
i
o
n
a
n
d
c
o
n
t
r
o
l
g
r
o
u
p
s
.
N
o
i
n
t
e
r
v
e
n
t
i
o
n
e
ﬀ
e
c
t
f
o
r
u
p
p
e
r
b
o
d
y
s
t
r
e
n
g
t
h
(
p
u
s
h
-
u
p
c
o
m
p
l
e
t
e
d
)
o
r
ﬂ
e
x
i
b
i
l
i
t
y
(
s
i
t
a
n
d
r
e
a
c
h
d
i
s
t
a
n
c
e
)
.
S
e
l
f
-
r
e
p
o
r
t
e
d
P
A
(
+
)
a
n
d
a
c
a
r
d
i
o
v
a
s
c
u
l
a
r
ﬁ
t
n
e
s
s
(
+
)
.
H
a
r
t
m
a
n
,
2
0
0
9
[
3
3
]
.
I
n
t
e
r
v
e
n
t
i
o
n
g
r
o
u
p
:
N
=
2
5
.
C
h
i
l
d
r
e
n
w
i
t
h
A
L
L
.
1
4
b
o
y
s
.
M
e
d
i
a
n
a
g
e
a
t
t
h
e
t
i
m
e
o
f
t
h
e
s
t
u
d
y
:
5
.
3
(
r
a
n
g
e
1
.
3
–
1
5
.
6
)
y
r
s
.
C
o
n
t
r
o
l
g
r
o
u
p
:
N
=
2
6
.
1
6
b
o
y
s
.
M
e
d
i
a
n
a
g
e
a
t
t
h
e
t
i
m
e
o
f
t
h
e
s
t
u
d
y
:
6
.
2
(
r
a
n
g
e
1
.
7
–
1
7
.
1
)
y
r
s
.
I
n
t
e
r
v
e
n
t
i
o
n
:
p
r
e
v
e
n
t
i
v
e
P
T
p
r
o
g
r
a
m
(
w
e
e
k
l
y
s
t
r
e
n
g
t
h
e
n
i
n
g
a
n
d
s
t
r
e
t
c
h
i
n
g
e
x
e
r
c
i
s
e
a
n
d
s
h
o
r
t
-
b
u
r
s
t
h
i
g
h
-
i
n
t
e
n
s
i
t
y
e
x
e
r
c
i
s
e
i
n
B
M
D
t
w
i
c
e
p
e
r
w
e
e
k
)
.
C
o
n
t
r
o
l
:
s
t
a
n
d
a
r
d
c
a
r
e
.
D
u
r
a
t
i
o
n
:
2
y
e
a
r
s
,
d
u
r
i
n
g
t
r
e
a
t
m
e
n
t
.
P
e
r
c
e
n
t
a
g
e
o
f
b
o
d
y
f
a
t
(
−
)
o
r
l
e
s
s
b
o
d
y
m
a
s
s
(
−
)
.
B
M
D
d
e
c
r
e
a
s
e
d
s
i
g
n
i
ﬁ
c
a
n
t
l
y
i
n
b
o
t
h
g
r
o
u
p
s
b
e
t
w
e
e
n
t
h
e
s
t
a
r
t
a
n
d
e
n
d
o
f
t
r
e
a
t
m
e
n
t
.
M
o
t
o
r
p
e
r
f
o
r
m
a
n
c
e
(
−
)
o
r
a
n
k
l
e
d
o
r
s
i
ﬂ
e
x
i
o
n
r
a
n
g
e
o
f
m
o
t
i
o
n
(
−
)
b
e
t
w
e
e
n
g
r
o
u
p
s
.
∗
(
+
)
t
o
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[35] investigated the eﬀects of an acute bout (30 minutes) of
exercise (heart rate 70–85% of peak oxygen uptake capacity
(VO2 peak)) on neutrophil counts and immune function
in children undergoing maintenance therapy for ALL (n =
4; mean age 11.3 ± 5 . 3y e a r s ) .T h e yf o u n dn od e l e t e r i o u s
eﬀects of this intervention on immune function. Their work
is supported by Chamorro-Vina et al. who demonstrated
that a daily 3-week in-hospital moderate intensity exercise
training regimen, including both supervised resistance and
aerobic components, did not aﬀect immune cell recovery
in 7 children who had undergone hematopoietic stem
cell transplantation [31]. This same group of authors also
report no signiﬁcant impact of a 3 times per week 16-
week aerobic and resistance training intervention on levels
of growth hormone, insulin-like growth factors, and insulin-
like growth binding proteins levels (IGFBP-2 and -3) [37]
in children with ALL. In this study, protein levels of IGFBPs
remained stable even after 20 weeks of detraining.
2.3. Eﬀe c to fE x e r c i s eo nt h eC a r d i o p u l m o n a r yS y s t e m . Cardi-
opulmonary ﬁtness is impaired in children during treatment
and among survivors of childhood cancer [9, 10]. Reports of
the eﬀects of exercise intervention on the cardiopulmonary
system during treatment are mixed. Marchese et al. [21]
examined eﬀects of exercise on cardiovascular response in
children (aged 4–15 years) receiving maintenance therapy
for ALL. Participants were randomly assigned into a physical
therapy (PT) intervention group with home-based aerobic
training two times per week (n = 13) or a control (non-
PT intervention) group (n = 15). Following a four-month
intervention, these authors reported no cardiopulmonary
response to training as assessed by a nine minute run-
walk test. Additionally, more than 50% of the children
scored below the 25th percentile for cardiopulmonary ﬁtness
when compared to the normative sample in the American
Alliance of Health, Physical Education, Recreation and
Dance Association Guidelines at both the pre- and posttest
assessments. Similarly, Takken et al. [40] implemented a
12-week community-based exercise program in 9 children
with ALL (aged 6–14 years) and found no cardiopulmonary
response to training as assessed by standardized cardiopul-
monary exercise testing. Of note, some children in this
study complained that the training program was boring,
too intense, and hard to combine with their other activities
which may have limited compliance. Moyer-Mileur et al.
[36], who provided a home-based intervention to children
with ALL during the maintenance phase of chemotherapy,
report slightly more promising results. In a much longer
duration intervention, with a perhaps more palatable inten-
sityoftraining,theyassignedthirteen4–10-year-oldchildren
to either 15–20 minutes of moderate to vigorous physical
activity 3 times per week (n = 6) or to no intervention
(n = 7). After 12 months, regular physical activity and
cardiopulmonary ﬁtness were assessed with a pedometer and
a Progressive Aerobic Cardiovascular Endurance Run test
(PACER) [49], respectively. The authors reported that the
exercise group recorded more steps on the pedometer (P =
0.06, Cohen’s d = 1.12) and performed slightly better on the
PACER (P = 0.05, Cohen’s d = 1.22) than the control group
at the end of the intervention.
It appears that hospital type supervised exercise inter-
ventions have better cardiopulmonary outcomes than do
those that are home or community based. San Juan et al. [9]
reported positive results after implementation of a 16-week
supervised (in-person) exercise program among 7 children
with ALL, 4–7 years of age, also during the maintenance
phase of chemotherapy. Their study population achieved
a signiﬁcant increase in both ventilatory threshold (before
training 15.8 ± 3.3; after training 20.7 ± 2.9 milliliters per
kilogram per minute (mL/kg/min), P<0.05, Cohen’s d =
1.58) and peak oxygen uptake (before training 24.3 ± 5.9;
after training 30.2 ± 6.2mL/kg/min, P<0.05, Cohen’s
d = 0.97). A subsequent study by San Juan et al. [9] showed
similar beneﬁts for an 8-week supervised exercise training
program among 8 children after HCT.
Supervised exercise training also appears to have promise
for childhood cancer survivors with long-term cardiopul-
monary compromise. A study by Sharkey et al. [38] exam-
ined the eﬀects of a 12-week aerobic training program
among childhood cancer survivors who had been treated
with anthracycline chemotherapy (cumulative dosage 349 ±
69 milligrams per meter squared (mg/m2)). Among the 10
patientswhocompletedthetwiceweeklyprogram(meanage
19 ± 3 years; mean time since diagnosis 8 ± 4 years), there
was an average increase in exercise time on cardiopulmonary
exercise testing (CPET) of 13 percent (%) from before to
after test (P<0.05, Cohen’s d = 0.47). They also reported
a trend toward improvement in peak oxygen uptake (P =
NS, Cohen’s d = 0.36) and anaerobic threshold (P = NS,
Cohen’s d = 0.58), but no signiﬁcant changes in body
fat, spirometer parameters, cardiac index, or stroke volume
index. Unfortunately, although these 10 participants showed
some improvement in exercise tolerance, their exercise
capacity remained substantially lower than those of normal
subjects.
2.4. Eﬀect of Exercise on the Musculoskeletal System. Cancer
therapy in children also impacts the musculoskeletal system.
Limited range of motion, loss of muscle mass, and reduced
muscle strength are common among children with cancer
and among survivors [33, 50–52]. Fortunately, the early
intervention research targeting these impairments is very
promising. Improved muscle strength and ﬂexibility is
reported following training among children during mainte-
nance therapy for ALL [9, 21] and in groups of children with
mixed cancer diagnoses [34]. In their 12-week home-based
PT intervention for children during maintenance therapy for
ALL (n = 13 intervention group, n = 15 control group),
Marchese et al. [21] reported that stretching and resistance
training improved ankle range of motion (P<0.01, Cohen’s
d = 0.62) and knee extension strength (P<0.01, Cohen’s
d = 0.35). In another intervention during ALL maintenance
therapy among 7 children 4–7 years of age, San Juan et al. [9]
implementedresistancetrainingforthemajormusclegroups
and reported muscle strength gains (P<0.05, Cohen’s d =
0.85to1.48)afterjusteightweeksoftraining[9].Thesegains8 International Journal of Pediatrics
were maintained after a 20-week detraining period [9]. In a
longer intervention program (2 years) designed to prevent
bone loss in children during treatment for ALL (intervention
group n = 25, control group n = 26) Hartman et al. [33]
reported that stretching and twice daily short-burst high-
intensity exercise resulted in improved dorsiﬂexion range of
motion (P = 0.001, Cohen’s d = 0.94), but not in improved
bone health. In a group-based physical activity intervention
with a group of adolescent cancer survivors with mixed
diagnoses (n = 10), Keats and Culos-Reed [34]r e p o r t e d
improved upper body strength (P<0.05, Cohen’s d = 0.64)
after 16 weeks of participation.
2.5. Eﬀe c to fE x e r c i s eo nF a t i g u e .Fatigue is a common
symptom in children during and following cancer treatment
[53, 54]. Both exercise and EPA type interventions show
some eﬃcacy in the management of fatigue during and
after cancer chemotherapy in children [30, 34]. However,
it appears that fatigue reduction also requires a training
response. Inthreestudies, wheretheresponse totraining was
positive, fatigue reduction was evident and even persisted,
whereas in one study, where the exercise response was null,
sowasthefatiguereductionresponse.Yehetal.[41]r eported
reduced levels of fatigue (P = 0.03, Cohen’s d = 0.54)
among children with ALL (n = 12) who completed a six-
week home-based aerobic exercise program when compared
to a control group who did not (n = 10), and Blaauwbroek
et al. [30] reported reduced levels of fatigue (P<0.005,
Cohen’s d =− 0.92) and increased levels of physical activity
(P<0.005, Cohen’s d = 0.94) after 10 weeks of a home-
based physical activity counseling intervention in childhood
cancer survivors. The Blaauwbroek study was implemented
in survivors (n = 38) who were on average 30 years
of age and 22 years from their original cancer diagnosis.
Importantly, fatigue reduction was maintained in their study
population at a three-year follow-up time point. The results
of a study by Keats and Culos-Reed [34] also demonstrated
a reduction in fatigue (P = 0.01, Cohen’s d = 0.69)
after a 16-week group-based physical activity intervention in
survivors of pediatric cancer (n = 10). In contrast, a 12-week
community-basedexercisetrainingprogramwheretherewas
no exercise response, perhaps because of noncompliance,
also demonstrated no fatigue reduction response (P = NS,
Cohen’s d =− 0.26) [40].
2.6. Eﬀect of Exercise on General Physical Functioning. Sup-
pressed immune system function, poor cardiopulmonary
ﬁtness, reduced muscle strength, and fatigue may decrease
the ability of a child with cancer or a childhood cancer sur-
vivor to participate comfortably in regular physical activity.
Implementation of a program of exercise or EPA, on the
other hand, may improve their strength and ﬁtness and, if it
alleviates fatigue, may increase ease of movement and enable
activities that have a physical component. The evidence for
eﬃcacy of exercise and EPA programs to improve overall
physical functioning and mobility in survivors of pediatric
cancer is mixed. Among children with ALL, four diﬀerent
exercise intervention studies have documented the beneﬁcial
eﬀects of a supervised training program or home-based
exercise [9, 32] on general physical functioning, whereas
three other studies have failed to ﬁnd a positive eﬀect
of exercise on physical functioning [21, 33, 40]. Like the
impact of exercise on fatigue, the impact of exercise on
physical functioning appears to require that the intervention
have a training eﬀect. San Juan et al. in their series of
three manuscripts (n = 7) demonstrated that a supervised
training program among young children with ALL or in
children following HCT, consisting of both resistance and
aerobic exercises, improved not only muscle strength and
cardiopulmonary ﬁtness but also functional mobility as
assessed by performance on three and ten meter timed
up and go (TUG) tests (Cohen’s d −0.63 to −1.53, P<
0.05) [9]. Gohar et al. [32]r e p o r t e di m p r o v e dg r o s sm o t o r
function in nine children after implementing individualized
home-based exercise programs during the early phases of
treatment for ALL in nine children. However, the twelve-
week supervised community-based intervention by Takken
et al. [40] among 9 children during the maintenance phase
of ALL treatment that had no training eﬀect also had no
impact on functional mobility. Additionally, Marchese et al.
[21], who demonstrated improvements in ankle range of
motion and knee extension strength, but no improvements
in cardiopulmonary ﬁtness (P = 0.25, Cohen’s d = 0.57)
after implementation of a 16-week home program during
maintenance therapy for children (intervention group n =
13, control group n = 15) with ALL, also reported no
improvements in performance on the TUG test (P = 0.17,
Cohen’s d =− 0.55).
2.7. Eﬀect of Exercise on Health-Related Quality of Life. Six
of the studies we reviewed reported a health-related quality
of life outcome (HRQOL) in response to exercise training
or EPA [9, 21, 32, 34, 39]. Four reported a positive eﬀect
and two no eﬀect. Positive eﬀects were found in three
studies with no control population, making it diﬃcult to
attribute the outcomes to the intervention rather than to
developmental maturation or disease recovery. Gohar et al.
[32]a n dS p e y e re ta l .[ 39]b o t hr e p o r to v e r a l li m p r o v e m e n t
in HRQOL in response (P<0.001, Cohen’s d = 1.43 to 2.32)
to an individualized home-based exercise intervention [32]
or to an in-hospital adapted physical activity intervention
[39] among children during acute phases of treatment.
Interestingly,thestudybyGoharetal.[32]reportedaninitial
reduction in HRQOL when chemotherapy was intensiﬁed
during treatment among 9 children with ALL. San Juan et
al. [9] also reported improved HRQOL (P<0.05, Cohen’s
d = 1.1) in response to their 8-week long supervised exercise
intervention among 8 children following HCT, and Keats
and Culos-Reed [34], in a group of 10 adolescent cancer
survivors with mixed diagnoses, reported improved HRQOL
(P = 0.01, Cohen’s d = 0.34) after a sixteen-week physical
activity and educational intervention. These results in the
adolescent survivors of mixed diagnoses persisted for at least
one year following the end of the intervention. In contrast to
the results of their study among children following HCT, San
Juan et al. reported no eﬀect of exercise training on HRQOLInternational Journal of Pediatrics 9
(P = NS, Cohen’s d = 0.31 to 0.58) among 7 children who
received 16-week supervised exercise intervention during
maintenance therapy for ALL [9]. This ﬁnding is similar to
that of Marchese et al., who also reported no diﬀerences
between the intervention (n = 13) and control (n = 15)
groups on HRQOL in their study of the eﬀects of a 16-
week home-based PT intervention among children during
maintenance therapy for childhood ALL [21].
3. Conclusion
It appears that exercise training can be safely undertaken
during treatment for ALL and HCT with no major eﬀects on
the immune system and that exercise does not have a dele-
terious eﬀect on growth factors during treatment for ALL.
The published evidence is positive for the impact of exercise
on muscle strength and ﬂexibility and mixed for the impact
of exercise intervention on cardiopulmonary ﬁtness among
children with ALL during maintenance therapy, among
children following HCT, and among survivors exposed to
cardiotoxic agents. Fatigue and general physical function are
enhanced if the intervention generates a cardiopulmonary
training eﬀect. The evidence for the eﬀects of exercise
training on HRQOL in the childhood cancer population is
mixed and diﬃcult to disentangle from the eﬀects of disease
recoveryandnormalmaturation.Theearlyevidencesuggests
that supervised hospital training is eﬀective, likely because
compliance and training intensity are assured. Home- or
c o m m u n i t y - b a s e dp r o g r a m sa p p e a rt ob el e s se ﬀective.
Unfortunately, supervised training is expensive and often
unrealistic for families who may have to travel long distances
to a center that specializes in cancer care.
Even though early results are promising, speciﬁc limi-
tations in the existing literature do not allow us to yet be
able to state with conﬁdence that exercise interventions oﬀer
clear beneﬁts during or after treatment for childhood cancer.
There have only been four randomized trials, sample sizes
have been small, and diagnosis groups included in the trials
have been very limited (mostly ALL). Intent to treat type
of analysis has not always been completed, and mechanisms
to characterize the eﬀects of participant dropout have not
been employed. In addition, inconsistencies in exercise
type, duration, and frequency, and outcome measurement
prohibit conclusions that might guide how an individual
clinician might prescribe exercise in practice.
Further research is needed. Studies designed to identify
and characterize the type and intensity of exercise necessary
to achieve clinically meaningful positive cardiopulmonary,
musculoskeletal, symptom limiting, physical function, and
quality of life outcomes in children with a variety of diag-
noses are necessary. These interventions must be not only
safe but also realistic and portable so that children, families,
and long-term survivors can adopt and incorporate exercise
and physical activity into their everyday lives when they are
not near the specialized center that provides care for children
with cancer. Additionally, larger well-designed randomized
studies that employ strong statistical methodology and that
evaluate the eﬀects of participant dropout on the outcomes
are important to see if the early results from these multiple
small, mostly observational trials remain positive in larger
populations of children with varied cancer diagnoses.
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